Genelux Common Stock Price To Earnings To Growth
| GNLX Stock | 2.69 0.20 8.03% |
Genelux Common fundamentals help investors to digest information that contributes to Genelux Common's financial success or failures. It also enables traders to predict the movement of Genelux Stock. The fundamental analysis module provides a way to measure Genelux Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genelux Common stock.
Genelux | Price To Earnings To Growth |
Genelux Common Company Price To Earnings To Growth Analysis
Genelux Common's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Genelux Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Genelux Common is extremely important. It helps to project a fair market value of Genelux Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Genelux Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Genelux Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Genelux Common's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Genelux Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Genelux Common has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Genelux Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genelux Common's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genelux Common could also be used in its relative valuation, which is a method of valuing Genelux Common by comparing valuation metrics of similar companies.Genelux Common is currently under evaluation in price to earnings to growth category among its peers.
Genelux Common ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Genelux Common's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Genelux Common's managers, analysts, and investors.Environmental | Governance | Social |
Genelux Fundamentals
| Return On Equity | -0.89 | ||||
| Return On Asset | -0.45 | ||||
| Current Valuation | 60.89 M | ||||
| Shares Outstanding | 34.54 M | ||||
| Shares Owned By Insiders | 16.28 % | ||||
| Shares Owned By Institutions | 15.70 % | ||||
| Number Of Shares Shorted | 1.42 M | ||||
| Price To Book | 2.81 X | ||||
| Price To Sales | 11,613 X | ||||
| Revenue | 170 K | ||||
| Gross Profit | 11.07 M | ||||
| EBITDA | (26.46 M) | ||||
| Net Income | (28.3 M) | ||||
| Total Debt | 2.52 M | ||||
| Book Value Per Share | 0.74 X | ||||
| Cash Flow From Operations | (20.27 M) | ||||
| Short Ratio | 8.90 X | ||||
| Earnings Per Share | (0.94) X | ||||
| Target Price | 18.4 | ||||
| Number Of Employees | 24 | ||||
| Market Capitalization | 92.91 M | ||||
| Total Asset | 27.89 M | ||||
| Retained Earnings | (221.52 M) | ||||
| Working Capital | 17.65 M | ||||
| Net Asset | 27.89 M |
About Genelux Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genelux Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genelux Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genelux Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.